Who
Jonathan Yen-Wen Yu
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, Disc Medicine.
In numbers
- Trades disclosed
- 66
- Buys
- 0
- Sells
- 10
- Bought
- $0
- Sold
- $8.7M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 29 Dec 2022
- Last trade
- 25 Aug 2026
- Last filed
- 26 Aug 2026
Companies traded
Activity over time
1 Feb 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Aug 2026filed 26 Aug 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Code M | $119K8,796 at $13.50 | filing |
| 25 Aug 2026filed 26 Aug 2026 | IRON Disc Medicineoption or derivative · Biotechnology | SEC FORM 4 Code M | —8,796 at $0.00 | filing |
| 25 Aug 2026filed 26 Aug 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Sold | $731K8,796 at $83.12 | filing |
| 25 Aug 2026filed 26 Aug 2026 | IRON Disc Medicineoption or derivative · Biotechnology | SEC FORM 4 Code M | —8,796 at $0.00 | filing |
| 25 Aug 2026filed 26 Aug 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Code M | $119K8,796 at $13.50 | filing |
| 25 Aug 2026filed 26 Aug 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Sold | $731K8,796 at $83.12 | filing |
| 24 Aug 2026filed 26 Aug 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Code M | $4,050300 at $13.50 | filing |
| 24 Aug 2026filed 26 Aug 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Sold | $25K300 at $82.53 | filing |
| 24 Aug 2026filed 26 Aug 2026 | IRON Disc Medicineoption or derivative · Biotechnology | SEC FORM 4 Code M | —300 at $0.00 | filing |
| 24 Aug 2026filed 26 Aug 2026 | IRON Disc Medicineoption or derivative · Biotechnology | SEC FORM 4 Code M | —300 at $0.00 | filing |
| 24 Aug 2026filed 26 Aug 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Code M | $4,050300 at $13.50 | filing |
| 24 Aug 2026filed 26 Aug 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Sold | $25K300 at $82.53 | filing |
| 12 Aug 2026filed 14 Aug 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Code M | $11K804 at $13.50 | filing |
| 12 Aug 2026filed 14 Aug 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Sold | $66K804 at $82.64 | filing |
| 12 Aug 2026filed 14 Aug 2026 | IRON Disc Medicineoption or derivative · Biotechnology | SEC FORM 4 Code M | —804 at $0.00 | filing |
| 12 Aug 2026filed 14 Aug 2026 | IRON Disc Medicineoption or derivative · Biotechnology | SEC FORM 4 Code M | —804 at $0.00 | filing |
| 12 Aug 2026filed 14 Aug 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Code M | $11K804 at $13.50 | filing |
| 12 Aug 2026filed 14 Aug 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Sold | $66K804 at $82.64 | filing |
| 7 Jul 2026filed 9 Jul 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Code M | $1,350100 at $13.50 | filing |
| 7 Jul 2026filed 9 Jul 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Sold | $8,250100 at $82.50 | filing |
News
Disc Medicine (NASDAQ:IRON) Director Sells 10,994 Shares of StockIRON · themarketsdaily.com · 21 Oct 2026Disc Medicine Prices $450 Mln Offering Of Shares At $75/shr To Fund Pipeline DevelopmentIRON · finanzen.ch · 21 Oct 2026Disc Medicine Launches $350M Stock Offering Following Positive Phase 3 ResultsIRON · rttnews.com · 20 Oct 2026
0 headlines in the last 90 days name Jonathan Yen-Wen Yu; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.